Description: This 1979 session is about Non-Smoker Policies. Topics covered: 1. What data are available? How significant are they? 2. What are the effects of cigarette smoking on health? 3. In what ways can people be educated to stop or not start smoking cigarettes? 4. What are the possible policy implications of the foregoing for the life and health insurance business? 5. For policies with nonsmoker discounts, what are the pricing implications with respect to: a. Nature of the discount -Should it be guaranteed? b. Effect on standard class pricing? Deficiency reserves? Reinsurance? c. Competitive impact? 6. The application form: Information needed, and how do you get it?

Description: The presenters will share information about: -Insights into causes of death through the use of predictive models, based on a reinsured U.S. life portfolio, using logistic regression models to understand three main causes of death: cancer, heart and external causes; -Opioid abuse is a widespread phenomenon with drug-related mortality rates rising steeply in the U.S. over the past two decades. But what does the most recent data tell U.S. about the outlook for Opioid-related mortality?; -'Deaths of despair' have been publicized as a cause for the poor performance of U.S. mortality in recent years. The presenters will be looking at the different causes under this label, their evolution and explore the drivers behind them.

Description: Read the Quo Vadis Reinsurance.

Description: The management of the investments of an insurance enterprise has undergone a considerable evolution since the pioneering work of Redington in the mid 20th century. Best practices have evolved to incorporate ever more complex insurance liabilities, expanding investment asset classes and global market opportunities. Strategic asset allocation (SAA), liability driven investing, and other robust optimization approaches form the core of the professional management of insurance company investments.

Description: This 1978 discussion focused on Adjustable Life Products. Topics included: 1. Current status in marketplace. 2. Future expectations. 3. Product design. 4. Typical riders. 5. Strengths and weaknesses. 6. Administrative requirements.

Description: This article discusses the growing popularity of variable products and compares the product design and pricing of VUL and UL products.

Description: This article discusses the importance, measurement and improvement of product development efficiency.

Description: This paper considers in more detail the differences between provisions necessary for nonparticipating and those necessary for participating adjustable life policies and will provide a possible means of designing nonparticipating policies that can adjust directly to future changes in mortality and interest valuation bases. A discussion of the paper follows. From Transactions of Society of Actuaries 1979, Vol 31.

Description: 1999 SOA Regional Meeting, Atlanta. This session covered the process of rapid product issue and the implications that has from a marketing, underwriting, operational, product pricing, and design standpoint.

Description: This 1979 session is about Life Company performance measures and pricing. Topics included: 1. What are appropriate performance criteria? a. In terms of financial results b. In terms of growth 2. How are goals established? a. For Mutual companies b. For Stock companies 3. What measurement tools do we use? a. Comparison of actual to expected results b. Compound growth rates c. Rules of thumb for various performance ratios d. Analysis of source of earnings 4. How are results used in pricing? a. Pricing consistent with goals are goals consistent with projections? b. Problems relating to allocation by line